0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
100.00%
Revenue growth of 100.00% while XRF.AX is flat. Bruce Berkowitz would check if a small edge can widen further.
18.63%
Gross profit growth of 18.63% while XRF.AX is zero. Bruce Berkowitz would see if minimal improvements could expand further.
76.71%
EBIT growth of 76.71% while XRF.AX is zero. Bruce Berkowitz would see if small gains can be scaled further.
76.71%
Operating income growth of 76.71% while XRF.AX is zero. Bruce Berkowitz would see if this modest edge can become significant.
100.00%
Net income growth of 100.00% while XRF.AX is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
100.00%
EPS growth of 100.00% while XRF.AX is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
100.00%
Diluted EPS growth of 100.00% while XRF.AX is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
3.20%
Share change of 3.20% while XRF.AX is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
3.20%
Diluted share change of 3.20% while XRF.AX is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
100.00%
OCF growth of 100.00% while XRF.AX is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
100.00%
FCF growth of 100.00% while XRF.AX is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
120.46%
10Y revenue/share CAGR under 50% of XRF.AX's 244.08%. Michael Burry would suspect a lasting competitive disadvantage.
522.65%
5Y revenue/share CAGR above 1.5x XRF.AX's 44.05%. David Dodd would look for consistent product or market expansions fueling outperformance.
608.72%
3Y revenue/share CAGR above 1.5x XRF.AX's 50.26%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
9689.57%
10Y OCF/share CAGR above 1.5x XRF.AX's 21.55%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
692.97%
Positive OCF/share growth while XRF.AX is negative. John Neff might see a comparative advantage in operational cash viability.
1414.39%
Positive 3Y OCF/share CAGR while XRF.AX is negative. John Neff might see a big short-term edge in operational efficiency.
219.36%
Below 50% of XRF.AX's 1369.81%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
1837.97%
5Y net income/share CAGR above 1.5x XRF.AX's 1.24%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
6156.15%
3Y net income/share CAGR above 1.5x XRF.AX's 343.69%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
448.62%
5Y equity/share CAGR above 1.5x XRF.AX's 14.71%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
95.88%
3Y equity/share CAGR above 1.5x XRF.AX's 12.63%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.10%
We have a declining book value while XRF.AX shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
8.49%
Debt growth of 8.49% while XRF.AX is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
24.21%
SG&A growth of 24.21% while XRF.AX is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.